{
    "clinical_study": {
        "@rank": "126090", 
        "arm_group": [
            {
                "arm_group_label": "AccuCath IV Catheter Device", 
                "arm_group_type": "Experimental", 
                "description": "AccuCath IV Catheter System will be used for IV therapy during inpatient stay.  Intervention includes vascular access, fluid infusion, and blood sample removal"
            }, 
            {
                "arm_group_label": "Conventional IV Catheter Device", 
                "arm_group_type": "Active Comparator", 
                "description": "Conventional IV catheter (current catheter) will be used for IV therapy during inpatient stay.  Interventions include vascular access, administration of fluids, and removal of blood samples."
            }
        ], 
        "brief_summary": {
            "textblock": "The study will test a hypothesis that the AccuCath\u2122 System will have a higher rate of\n      successful first attempt peripheral IV placement, higher completion of therapy, fewer\n      complications, longer dwell times and higher user satisfaction compared to Conventional IV\n      Catheters."
        }, 
        "brief_title": "RIVS (AccuCath Device) Versus (Conventional) PIV Catheter", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Vascular Access Complication", 
        "detailed_description": {
            "textblock": "This study is designed to evaluate user/physician preference as it relates to use of a\n      510(k) cleared vascular access and catheter device compared with conventional\n      needle/catheter vascular access devices, in terms of first stick success rates, dwell time,\n      device related vascular complications and adverse events and overall user and patient\n      satisfaction.  As noted above, the study is designed to formally test the hypothesis that\n      the AccuCath\u2122 System will exhibit superiority in terms of the rate of successful first\n      attempt peripheral IV placement, higher completion of therapy, fewer complications, longer\n      dwell times and higher user satisfaction compared to Conventional IV Catheters."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male or female, age > or equal to 18 years or < or equal to 89 years old;\n\n          2. Capable and willing to give informed consent;\n\n          3. English speaking;\n\n          4. Acceptable candidate for an elective, non-emergent PIV as determined by ordering\n             physician;\n\n          5. Admitted to study inpatient unit.\n\n        Exclusion Criteria:\n\n          1. Male or female, < 18 years old or > 89 years old;\n\n          2. Requirement for emergent IV placement (patient's condition would be compromised if\n             there is a delay in IV placement);\n\n          3. Previous venous grafts or surgery at the target vessel access site;\n\n          4. Currently involved in other investigational clinical trials (unless permission is\n             granted by other study PI);\n\n          5. Females who are pregnant, planning to become pregnant within 3 months of the\n             procedure, or lactating."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "89 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943474", 
            "org_study_id": "DDVP-001/VPW-STP-00004"
        }, 
        "intervention": [
            {
                "arm_group_label": "AccuCath IV Catheter Device", 
                "description": "Vascular access and indwelling catheter placement via study device for infusion of fluids and removal of blood samples.", 
                "intervention_name": "AccuCath IV Catheter Device", 
                "intervention_type": "Device", 
                "other_name": [
                    "RIVS (Rapid Intravascular Start System)", 
                    "AccuCath System", 
                    "AccuCath IV device"
                ]
            }, 
            {
                "arm_group_label": "Conventional IV Catheter Device", 
                "description": "Vascular access and indwelling catheter placement via control device for infusion of fluids and removal of blood samples.", 
                "intervention_name": "Conventional IV Catheter Device", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "IV Catheter comparison", 
            "AccuCath versus Conventional IV Catheters", 
            "IV Catheter Study", 
            "IV Catheter User Preference Comparison", 
            "First Attempt Success Rate for IV Catheters", 
            "AccuCath Device Performance", 
            "Complication Rates for IV Catheters", 
            "Average Dwell Time for IV Catheters", 
            "Patient Satisfaction with IV Catheters", 
            "Clinician Satisfaction with AccuCath Device Performance"
        ], 
        "lastchanged_date": "September 11, 2013", 
        "location": {
            "contact": {
                "email": "bette.idemoto@uhhospitals.org", 
                "last_name": "Bette Idemoto, PhD, RN", 
                "phone": "216-844-2202"
            }, 
            "facility": {
                "address": {
                    "city": "Cleveland", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "44106"
                }, 
                "name": "University Hospitals Case Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "James Rowbottom, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Bette Idemoto, PhD, RN", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Non-Blinded, Randomized Controlled, Study Designed to Evaluate User Preferences Associated With the Rapid Intravascular Start (RIVS/AccuCath) System Versus Conventional Catheters for Peripheral Intravenous (PIV) Access", 
        "overall_contact": {
            "email": "bette.idemoto@uhhospitals.org", 
            "last_name": "Bette Idemoto, PhD, RN", 
            "phone": "216-844-2202"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Case Medical Center", 
            "last_name": "James Rowbottom, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcomes measure is to observe first attempt success rate in patients requiring peripheral IV access by documenting the number of catheter attempts (each new catheter) required to complete successful peripheral IV placement.", 
            "measure": "First attempt success rate with peripheral IV catheter placement", 
            "safety_issue": "No", 
            "time_frame": "baseline/at catheter placement"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943474"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Completion of IV therapy will measure whether the catheter remained in place for the duration of required intravenous treatment during the inpatient stay (up to 7 days).", 
                "measure": "Completion of IV therapy", 
                "safety_issue": "No", 
                "time_frame": "Study exit/At catheter removal (up to 7 days)"
            }, 
            {
                "description": "Will measure the rate of observed (anticipated) complications of IV therapy - infection, occlusion, infiltration, extravasation, phlebitis, dislodgement, leaking/bleeding at site, patient complaints of pain without other identifiable cause, and other (up to 7 days).", 
                "measure": "Complications of peripheral IV therapy", 
                "safety_issue": "No", 
                "time_frame": "Study Exit/At catheter removal (up to 7 days)"
            }, 
            {
                "description": "Will measure total catheter dwell time to the nearest hour (total time in hours for functioning catheter)up to 7 days.", 
                "measure": "Catheter Dwell Time", 
                "safety_issue": "No", 
                "time_frame": "Study Exit/At catheter removal (up to 7 days)"
            }, 
            {
                "description": "Will survey patients regarding satisfaction with catheter insertion and overall performance during use of peripheral IV catheter.", 
                "measure": "Patient Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "Baseline at catheter insertion and study exit at catheter removal (up to 7 days)"
            }, 
            {
                "description": "Will measure clinician satisfaction via a survey based on overall catheter performance during experience and use.", 
                "measure": "Clinician satisfaction", 
                "safety_issue": "No", 
                "time_frame": "At end of study"
            }, 
            {
                "description": "Will measure the number and severity of adverse events associated with peripheral IV initiation and indwelling catheter time (anticipated to be similar in both groups)up to 7 days.", 
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, during and study exit."
            }
        ], 
        "source": "Vascular Pathways, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vascular Pathways, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}